Mar 6, 2026 02:51AM
Mar 3, 2026 05:31PM
Feb 27, 2026 07:13AM
Feb 27, 2026 07:00AM
Feb 24, 2026 09:30AM
Feb 24, 2026 09:30AM
Feb 24, 2026 09:30AM Dupixent® (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS)
Feb 19, 2026 07:00AM
Feb 19, 2026 07:00AM
Feb 17, 2026 05:31PM
Feb 16, 2026 05:31PM
Feb 10, 2026 07:00AM
Feb 10, 2026 07:00AM
Feb 9, 2026 07:17AM Regeneron Pharma (REGN) PT Raised to $975 at Guggenheim
Feb 2, 2026 07:00AM
Feb 2, 2026 07:00AM
Dec 23, 2025 04:42AM
Dec 23, 2025 01:00AM
Dec 8, 2025 02:52AM
Dec 7, 2025 04:30PM
Dec 1, 2025 07:09AM Regeneron and Tessera partner on gene editing therapy for rare disease
Dec 1, 2025 07:00AM
Nov 25, 2025 03:23AM
Nov 25, 2025 01:00AM
Nov 25, 2025 01:00AM
Nov 20, 2025 05:42AM
Nov 20, 2025 03:40AM
Nov 19, 2025 04:46PM After-hours movers: NVIDIA, CoreWeave, Palo Alto Networks, and more
Nov 19, 2025 04:10PM
Nov 19, 2025 04:10PM
Nov 19, 2025 07:00AM
Nov 19, 2025 07:00AM
Nov 13, 2025 07:02AM
Nov 13, 2025 07:00AM
Nov 8, 2025 10:46AM Regeneron reports positive phase 2 results for factor XI antibodies
Nov 8, 2025 10:46AM
Nov 7, 2025 08:00AM
Nov 7, 2025 08:00AM
Nov 7, 2025 08:00AM
Nov 7, 2025 08:00AM
Oct 31, 2025 07:00AM
Oct 29, 2025 10:25AM Regeneron Pharma (REGN) PT Raised to $740 at Cantor Fitzgerald
Oct 29, 2025 07:26AM
Oct 17, 2025 07:30AM
Oct 17, 2025 07:30AM
Oct 15, 2025 07:02AM
Oct 15, 2025 07:00AM
Oct 13, 2025 11:16AM
Oct 12, 2025 10:18AM DB-OTO Results in the New England Journal of Medicine Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss
Oct 8, 2025 02:33PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All